Mill Creek Capital Advisors, LLC Precigen, Inc. Transaction History
Mill Creek Capital Advisors, LLC
- $4.09 Billion
- Q3 2024
A detailed history of Mill Creek Capital Advisors, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Mill Creek Capital Advisors, LLC holds 110,000 shares of PGEN stock, worth $90,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110,000Holding current value
$90,200% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PGEN
# of Institutions
144Shares Held
159MCall Options Held
232KPut Options Held
69K-
Third Security, LLC83.5MShares$68.4 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$14.7 Million0.92% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$8.91 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$8.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$6.83 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $171M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...